X4 Pharmaceuticals Inc logo

X4 Pharmaceuticals Inc

NEW
NAS:XFOR (USA)  
$ 4.02 +0.015 (+0.37%) 04:00 PM EST
At Loss
P/B:
2.25
Market Cap:
$ 379.16M
Enterprise V:
$ 222.69M
Volume:
9.45M
Avg Vol (2M):
407.04K
Trade In:
Volume:
9.45M
At Loss
Avg Vol (2M):
407.04K

GF Valueâ„¢

X4 Pharmaceuticals Inc’s share price is $4.02. Its GF Value is $0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes X4 Pharmaceuticals Inc stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: $4.02 GF Value Price/GF Value
Current $0 Infinity
Next FY1 End $0 Infinity
Next 12 Month $0 Infinity
Next FY2 End $0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing X4 Pharmaceuticals Inc's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between X4 Pharmaceuticals Inc's stock price and Book Value per share, with a coefficient of 92%. X4 Pharmaceuticals Inc’s stock price shows no significant correlation with Revenue per share. X4 Pharmaceuticals Inc’s stock price shows no significant correlation with Earnings without NRI per share. X4 Pharmaceuticals Inc’s stock price shows no significant correlation with Operating Cash Flow per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies